Yeztugo Tablet, Film Coated
Product Images NDC 61958-3401

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Yeztugo (NDC 61958-3401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Yeztugo 01)

Yeztugo kit packaging label showing contents: two vials, two syringes, two 18-gauge 1½ inch withdrawal needles, and two 22-gauge ½ inch injection needles. All components are indicated for single use. Labeler is Gilead Sciences, Inc.*

FDA Label Image

Figure 2 (Yeztugo 02)

An instructional diagram detailing the preparation and administration of Yeztugo 300 mg/1 kit injection. Steps include vial preparation, attaching needles, expelling air bubbles, selecting injection sites at least 2 inches from the navel, injecting 1.5 mL subcutaneously, and administering a second injection at least 4 inches from the first site. The diagram highlights needle hub colors and proper angles for injection.*

FDA Label Image

Chemical Structure (Yeztugo 03)

Chemical structure of lenacapavir sodium, the active ingredient in Yeztugo, showing its detailed molecular formula including fluorine, chlorine, sodium, trifluoromethyl, and sulfonyl groups.*

FDA Label Image

Principal Display Panel (4 Tablet Bottle Label)

Label for Yeztugo (lenacapavir) tablets, 300 mg per tablet, provided as a kit of 4 tablets. The label states storage instructions, manufacturing details by Gilead Sciences, Inc., and a caution to keep out of reach of children. NDC 61958-3401-1 is displayed along with a reminder to consult a healthcare provider before use.*

FDA Label Image

Principal Display Panel (Kit Carton)

Yeztugo (lenacapavir) injection label showing a dose strength of 463.5 mg/1.5 mL (309 mg/mL) for subcutaneous injection. The kit includes 2 single-dose vials, withdrawal needles, syringes, injection needles, prescribing information, usage instructions, and patient information. The label is for healthcare professional administration only and is by Gilead Sciences, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.